Leidos Holdings, Inc. (NYSE:LDOS) Shares Bought by Oppenheimer & Co. Inc.

Oppenheimer & Co. Inc. lifted its stake in shares of Leidos Holdings, Inc. (NYSE:LDOS) by 73.7% during the third quarter, Holdings Channel.com reports. The fund owned 5,366 shares of the aerospace company’s stock after purchasing an additional 2,277 shares during the period. Oppenheimer & Co. Inc.’s holdings in Leidos were worth $875,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in LDOS. Boston Partners raised its stake in shares of Leidos by 5.8% in the 1st quarter. Boston Partners now owns 3,430,264 shares of the aerospace company’s stock worth $449,592,000 after buying an additional 188,458 shares in the last quarter. Millennium Management LLC lifted its holdings in Leidos by 156.5% in the 2nd quarter. Millennium Management LLC now owns 1,133,508 shares of the aerospace company’s stock valued at $165,356,000 after acquiring an additional 691,575 shares during the last quarter. Allspring Global Investments Holdings LLC boosted its position in shares of Leidos by 51.2% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 837,370 shares of the aerospace company’s stock valued at $136,491,000 after purchasing an additional 283,558 shares in the last quarter. Panagora Asset Management Inc. grew its stake in shares of Leidos by 39.7% in the 2nd quarter. Panagora Asset Management Inc. now owns 782,161 shares of the aerospace company’s stock worth $114,102,000 after purchasing an additional 222,179 shares during the last quarter. Finally, AQR Capital Management LLC raised its holdings in shares of Leidos by 76.9% in the 2nd quarter. AQR Capital Management LLC now owns 698,807 shares of the aerospace company’s stock worth $101,942,000 after purchasing an additional 303,775 shares in the last quarter. Institutional investors own 76.12% of the company’s stock.

Insiders Place Their Bets

In other Leidos news, Director Surya N. Mohapatra sold 2,748 shares of the business’s stock in a transaction on Thursday, November 7th. The shares were sold at an average price of $194.97, for a total transaction of $535,777.56. Following the completion of the transaction, the director now owns 20,001 shares of the company’s stock, valued at $3,899,594.97. The trade was a 12.08 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Robert C. Kovarik, Jr. sold 1,047 shares of the firm’s stock in a transaction dated Thursday, October 31st. The shares were sold at an average price of $184.94, for a total value of $193,632.18. Following the completion of the sale, the director now directly owns 6,408 shares in the company, valued at approximately $1,185,095.52. This represents a 14.04 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 0.96% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have issued reports on LDOS shares. Wells Fargo & Company upped their price target on Leidos from $183.00 to $230.00 and gave the company an “overweight” rating in a report on Wednesday, October 30th. Truist Financial upped their target price on Leidos from $175.00 to $205.00 and gave the company a “buy” rating in a report on Wednesday, October 30th. Royal Bank of Canada lifted their price target on Leidos from $145.00 to $180.00 and gave the stock a “sector perform” rating in a research note on Wednesday, October 30th. JPMorgan Chase & Co. upped their price objective on shares of Leidos from $175.00 to $185.00 and gave the company an “overweight” rating in a research note on Wednesday, October 2nd. Finally, Robert W. Baird lifted their target price on shares of Leidos from $180.00 to $218.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 30th. Two analysts have rated the stock with a hold rating, eleven have issued a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $191.23.

Leidos Price Performance

Shares of LDOS opened at $158.28 on Wednesday. The company has a debt-to-equity ratio of 0.87, a quick ratio of 1.15 and a current ratio of 1.23. The firm has a market cap of $21.12 billion, a PE ratio of 18.09, a PEG ratio of 1.08 and a beta of 0.68. The firm’s 50 day moving average price is $169.66 and its 200 day moving average price is $155.76. Leidos Holdings, Inc. has a twelve month low of $104.72 and a twelve month high of $202.90.

Leidos (NYSE:LDOS) last released its quarterly earnings data on Tuesday, October 29th. The aerospace company reported $2.93 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.96 by $0.97. The business had revenue of $4.19 billion during the quarter, compared to analyst estimates of $4.06 billion. Leidos had a net margin of 7.37% and a return on equity of 30.31%. Leidos’s quarterly revenue was up 6.9% compared to the same quarter last year. During the same quarter in the previous year, the business earned $2.03 EPS. As a group, research analysts expect that Leidos Holdings, Inc. will post 10.07 EPS for the current fiscal year.

Leidos Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 31st. Investors of record on Monday, December 16th will be issued a $0.40 dividend. This is a positive change from Leidos’s previous quarterly dividend of $0.38. This represents a $1.60 annualized dividend and a yield of 1.01%. The ex-dividend date is Monday, December 16th. Leidos’s payout ratio is 17.31%.

About Leidos

Leidos Holdings, Inc, together with its subsidiaries, provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. The company operates through Defense Solutions, Civil, and Health segments. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S.